T0	Outcomes 1287 1345	weeks, American College of Rheumatology 20/50/70 responses
T1	Outcomes 1456 1460	91).
T2	Outcomes 1461 1519	European League Against Rheumatism good/moderate responses
T3	Outcomes 1575 1579	90).
T4	Outcomes 1580 1636	Rates of adverse events (AE), serious AE, and infections
T5	Outcomes 1656 1663	stable.
T6	Outcomes 1664 1696	Rate of progressive joint damage
T7	Outcomes 1818 1825	groups.
T8	Outcomes 1826 1858	Mean change from baseline in PJD